Accurate long-range forecasting of COVID-19 mortality in the USA

par Pouria Ramazi, Arezoo Haratian, Maryam Meghdadi, Arash Mari Oriyad, Mark A. Lewis, Zeinab Maleki, Roberto Vega, Hao Wang, David S. Wishart, Russell Greiner
Publié 2021

CpG-ODN induced antimicrobial immunity in neonatal chicks involves a substantial shift in serum metabolic profiles

par Kalhari Bandara Goonewardene, Naama Karu, Khawaja Ashfaque Ahmed, Shelly Popowich, Betty Chow-Lockerbie, Lisanework E. Ayalew, Ruwani Karunarathna, Thushari Gunawardana, Mengying Liu, Suresh K. Tikoo, Marianna Foldvari, Philip Willson, Rupasri Mandal, David S. Wishart, Susantha Gomis
Publié 2021

The human urine metabolome.

par Souhaila Bouatra, Farid Aziat, Rupasri Mandal, An Chi Guo, Michael R Wilson, Craig Knox, Trent C Bjorndahl, Ramanarayan Krishnamurthy, Fozia Saleem, Philip Liu, Zerihun T Dame, Jenna Poelzer, Jessica Huynh, Faizath S Yallou, Nick Psychogios, Edison Dong, Ralf Bogumil, Cornelia Roehring, David S Wishart
Publié 2013

Targeted metabolomics identifies high performing diagnostic and prognostic biomarkers for COVID-19

par Yamilé López-Hernández, Joel Monárrez-Espino, Ana-Sofía Herrera-van Oostdam, Julio Enrique Castañeda Delgado, Lun Zhang, Jiamin Zheng, Juan José Oropeza Valdez, Rupasri Mandal, Fátima de Lourdes Ochoa González, Juan Carlos Borrego Moreno, Flor M. Trejo-Medinilla, Jesús Adrián López, José Antonio Enciso Moreno, David S. Wishart
Publié 2021

A Canadian Study of Cisplatin Metabolomics and Nephrotoxicity (ACCENT): A Clinical Research Protocol

par Anshika Jain, Ryan Huang, Jasmine Lee, Natasha Jawa, Yong Jin Lim, Mike Guron, Sharon Abish, Paul C. Boutros, Michael Brudno, Bruce Carleton, Geoffrey D. E. Cuvelier, Lakshman Gunaratnam, Cheryl Ho, Khosrow Adeli, Sara Kuruvilla, Giles Lajoie, Geoffrey Liu, Paul C. Nathan, Shahrad Rod Rassekh, Michael Rieder, Sushrut S. Waikar, Stephen A. Welch, Matthew A. Weir, Eric Winquist, David S. Wishart, Alexandra P. Zorzi, Tom Blydt-Hansen, Michael Zappitelli, Bradley Urquhart
Publié 2021

Metabolomics Profiling of Critically Ill Coronavirus Disease 2019 Patients: Identification of Diagnostic and Prognostic Biomarkers

par Douglas D. Fraser, MD, PhD, Marat Slessarev, MD, MSc, Claudio M. Martin, MD, MSc, Mark Daley, PhD, Maitray A. Patel, BSc, Michael R. Miller, PhD, Eric K. Patterson, PhD, David B. O’Gorman, PhD, Sean E. Gill, PhD, David S. Wishart, PhD, Rupasri Mandal, PhD, Gediminas Cepinskas, DVM, PhD, On behalf of the Lawson COVID19 Study Team, Robert Arntfield, Ian Ball, Gordon Barkwell, Tracey Bentall, Karen Bosma, Saoirse Cameron, Eileen Campbell, David Carter, Carolina Gillio-Meina, Robert Hegele, Natalya Odoardi, Ram Singh, Kelly Summers, Sue Tereschyn
Publié 2020